Xu, Li http://orcid.org/0009-0003-6836-3537
Wang, Yingcong
Wang, Guanli
Guo, Shushan
Yu, Dandan
Feng, Qilin
Hu, Ke
Chen, Gege
Li, Bo http://orcid.org/0000-0002-4279-4596
Xu, Zhijian http://orcid.org/0000-0002-3063-8473
Jia, Xinyan
Lu, Yumeng
Zhang, Hui
Gao, Xuejie
Chang, Shuaikang
Wang, Huaping
Wu, Xiaosong
Song, Dongliang
Yang, Guang
Zhu, Huabin
Zhou, Jinfeng
Zhan, Fenghuang http://orcid.org/0000-0001-5417-2973
Zhu, Weiliang http://orcid.org/0000-0001-6699-5299
Shi, Jumei http://orcid.org/0000-0002-8553-4559
Funding for this research was provided by:
National Natural Science Foundation of China (81870158, 82170200, 81900207, 22077131, 82070224, 81971529, 82000220)
Chinese Pharmaceutical Association-Yiling Biopharmaceutical Innovation Projiect
Article History
Received: 24 January 2023
Revised: 24 April 2023
Accepted: 28 April 2023
First Online: 8 May 2023
Competing interests
: The authors declare no competing interests.